Gene · 5891
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the molecular mechanism of Qingzao Decoction in the treatment of IgA vasculitis through network pharmacology and molecular docking. | Medicine (Baltimore) | 2026 | 41790715 | PubTator, text mining | PubMed |
| The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes. | Curr Hematol Malig Rep | 2026 | 41790379 | PubTator, text mining | PubMed |
| Unravelling the pathophysiology of diabetic foot ulcer: insights into a complex wound healing process. | Front Clin Diabetes Healthc | 2026 | 41789125 | PubTator, text mining | PubMed |
| Decoding lung-kidney interactions in sepsis: an integrated view of molecular mechanisms, pathophysiology, and therapeutic interventions. | Front Immunol | 2026 | 41789112 | PubTator, text mining | PubMed |
| Severe hypotension but not systemic inflammation or endothelial activation predicts encephalopathy in circulatory shock. | Ann Intensive Care | 2026 | 41788477 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Dynamic C-reactive protein trajectories predict prolonged healing time in diabetic wounds: a machine learning model based on a single-center cohort with standardized wound size. | Front Med (Lausanne) | 2026 | 41767538 | PubTator, text mining | PubMed |
| A retrospective clinical analysis of inappropriate Xiangdan Injection use: clinical risk profiling and computational hypothesis generation. | Front Pharmacol | 2026 | 41756235 | PubTator, text mining | PubMed |
| Novel AI-Driven Precision Strategies in Diabetic Wound Healing: Immunomodulation and Advances in Smart Composite Nanocarriers. | Pharmaceutics | 2026 | 41754993 | PubTator, text mining | PubMed |
| Beyond α-Glucosidase and α-Amylase Inhibition: Integrated In Vitro and Multi-Scale In Silico Insights into the Antidiabetic and Antioxidant Mechanisms of Oxalis corniculata L. Aerial Parts. | Molecules | 2026 | 41752406 | PubTator, text mining | PubMed |
| Differential microRNA Expression Profiles in Girls with Idiopathic Central Precocious Puberty and Premature Thelarche. | Int J Mol Sci | 2026 | 41751876 | PubTator, text mining | PubMed |
| Redox-Genomic Crosstalk: Linking Oxidative Stress, Sperm DNA Fragmentation, and Epigenetics in Personalized Management of Male Infertility. | J Pers Med | 2026 | 41745372 | PubTator, text mining | PubMed |
| Expression Analysis of VEGF-Related Hub Genes and Pathways in Breast Cancer: A Comprehensive Bioinformatics Analysis. | Iran J Med Sci | 2026 | 41743246 | PubTator, text mining | PubMed |
| Beyond glycemic control: molecular mechanisms of metformin in modulating cytokine networks in polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2026 | 41737049 | PubTator, text mining | PubMed |
| Environmental toxicant exposure and diabetes risk: An exposome-wide association study integrating mixture effects and molecular mechanisms. | Ecotoxicol Environ Saf | 2026 | 41734627 | PubTator, text mining | PubMed |
| Metabolic dysregulation: Its role in diabetes mellitus and cancers. | Mol Aspects Med | 2026 | 41734405 | PubTator, text mining | PubMed |
| Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy. | Mater Today Bio | 2026 | 41732388 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps in gynecological disease: pathogenic mechanisms and therapeutic opportunities. | Front Med (Lausanne) | 2026 | 41728621 | PubTator, text mining | PubMed |
| Macrophage-based therapeutic strategies in glioblastoma: advancements in drug delivery and immunotherapy. | Front Oncol | 2026 | 41727668 | PubTator, text mining | PubMed |
| The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. | Immun Inflamm Dis | 2026 | 41725222 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5891/papers?page=3